These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

680 related articles for article (PubMed ID: 8773423)

  • 21. Depot medroxyprogesterone. Management of side-effects commonly associated with its contraceptive use.
    Archer B; Irwin D; Jensen K; Johnson ME; Rorie J
    J Nurse Midwifery; 1997; 42(2):104-11. PubMed ID: 9107118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. WHO special programme of research, development and research training in human reproduction. Task force on long-acting agents for the regulation of fertility.
    Contraception; 1982 Jan; 25(1):1-11. PubMed ID: 6460593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Depot medroxyprogesterone acetate. Patterns of use and reasons for discontinuation.
    Paul C; Skegg DC; Williams S
    Contraception; 1997 Oct; 56(4):209-14. PubMed ID: 9408701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depo-Provera.
    Sharts-Hopko NC
    MCN Am J Matern Child Nurs; 1993; 18(2):128. PubMed ID: 8492647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Depo Provera: a profile of current users.
    Jarman H; Kovacs GT; Westcott M
    Aust N Z J Obstet Gynaecol; 1990 Feb; 30(1):74-6. PubMed ID: 2140675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
    Mainwaring R; Hales HA; Stevenson K; Hatasaka HH; Poulson AM; Jones KP; Peterson CM
    Contraception; 1995 Mar; 51(3):149-53. PubMed ID: 7621683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Return of fertility after use of the injectable contraceptive Depo Provera: up-dated data analysis.
    Pardthaisong T
    J Biosoc Sci; 1984 Jan; 16(1):23-34. PubMed ID: 6230362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of hormonal and nonhormonal contraceptives on lactation and incidence of pregnancy.
    Zacharias S; Aguilera E; Assenzo JR; Zanartu J
    Contraception; 1986 Mar; 33(3):203-13. PubMed ID: 2941236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The association between vaginal bleeding patterns and reasons for discontinuation of contraceptive use.
    Belsey EM
    Contraception; 1988 Aug; 38(2):207-25. PubMed ID: 2971506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Once-a-month injectable contraceptives: efficacy and reasons for discontinuation.
    Koetsawang S
    Contraception; 1994 Apr; 49(4):387-98. PubMed ID: 8013221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Some effects of depo-medroxyprogesterone acetate (DMPA): observations in the nursing infant and in the long-term user.
    Dahlberg K
    Int J Gynaecol Obstet; 1982 Feb; 20(1):43-8. PubMed ID: 6126406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A survey of different approaches to management of menstrual disturbances in women using injectable contraceptives.
    Fraser IS
    Contraception; 1983 Oct; 28(4):385-97. PubMed ID: 6230212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depo-Provera use in an Australian metropolitan practice.
    Fraser IS; Dennerstein GJ
    Med J Aust; 1994 May; 160(9):553-6. PubMed ID: 8164553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone density among long-term users of medroxyprogesterone acetate as a contraceptive.
    Paiva LC; Pinto-Neto AM; Faundes A
    Contraception; 1998 Dec; 58(6):351-5. PubMed ID: 10095971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone density in long term users of depot medroxyprogesterone acetate.
    Gbolade B; Ellis S; Murby B; Randall S; Kirkman R
    Br J Obstet Gynaecol; 1998 Jul; 105(7):790-4. PubMed ID: 9692421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum immunoglobulin levels during contraceptive use of depot-medroxyprogesterone acetate in Indian women: a preliminary study.
    Lali P; Chandra L; Gupta RP
    Contraception; 1996 Jun; 53(6):363-5. PubMed ID: 8773424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term depot-medroxyprogesterone acetate and bone mineral density.
    Tang OS; Tang G; Yip P; Li B; Fan S
    Contraception; 1999 Jan; 59(1):25-9. PubMed ID: 10342083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PFPP re-introduces DMPA.
    ICMH Newsl; 1994; 20(205):1. PubMed ID: 12318988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extracts from the report on the Joint IGCC/IFRP East and South East Asia Seminar on Regional Fertility Research.
    Mcdaniel EB
    IGCC News; 1980 Jan; 5(3):1-4. PubMed ID: 12179403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Contraception with injectable long-acting preparation depo-provera].
    Prilepskaia VN; Kondrikov NI; Tagieva TT
    Akush Ginekol (Mosk); 1995; (3):7-10. PubMed ID: 7653732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.